About Dadha Pharma Distribution Limited
Data last updated:
Dadha Pharma Distribution Limited is a public limited company based in Mumbai, Maharashtra, India, a subsidiary of Reliance Industries Limited. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 15 September 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74900MH2015PLC447671. Its GSTIN is 32AAFCD4589H2ZI (Kerala). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹81.16 Lakh. It is led by directors including Jethusingh Sohan Singh Bhati (Whole-Time Director) and Mohanchand Pradeep Dadha.
Its last annual general meeting (AGM) was held on 08 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹182.54 Cr, a decline of 7% compared to the previous year. For the same year it recorded a net loss of ₹19.9 Lakh (net margin -0.1%) and EBITDA of ₹2.5 Cr (EBITDA margin 1.4%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years and 7% over five years.
The company has about 33 employees on its provident fund (EPFO) records.
As per MCA filings, the company has satisfied charges of ₹20 Cr on record. The company has 5 deals on record (5 acquisitions); the latest was in March 2021. Its 5 peer companies in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading) are compared by revenue, 3 larger and 2 smaller; the largest is Livanova India Private Limited with revenue of ₹192.91 Cr.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website ril.com.
Company details
CIN history
Dadha Pharma Distribution has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U74900MH2015PLC447671, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U74900MH2015PLC447671 | Current |
| U74900TN2015PTC102202 | Previous |
| U74900TN2015PLC102202 | Previous |
Contact details
Dadha Pharma Distribution Limited's registered office is in Mumbai, Maharashtra. Its website is ril.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressFloor – 4 Plot – 298/302 Court House, Lokmanya Tilak Marg, Mumbai, Maharashtra, India – 400002
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Dadha Pharma Distribution Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Dadha Pharma Distribution is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Dadha Pharma Distribution Limited, buy the company report.
Financials of Dadha Pharma Distribution Limited
FY 2025 filings availableDadha Pharma Distribution Limited reported revenue of ₹182.54 Cr (down 7% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 7% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 7%. EBITDA fell 22% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.5 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹19.9 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.4% | ||||
| Net Profit Margin | -0.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Dadha Pharma Distribution Limited, buy the company report.
Board of directors of Dadha Pharma Distribution Limited
Dadha Pharma Distribution has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mohanchand Pradeep Dadha | Director | 15 Sep 2015 | 11 Years 1 Months | Current |
| Advait Suhas Pandit | Director | 21 Jan 2021 | 5 Years 9 Months | Current |
| Jethusingh Sohan Singh Bhati Also directs: Netmeds Healthcare Limited, Vitalic Health Limited | Whole-Time Director | 09 Oct 2015 | 11 Years 1 Months | Current |
Peer comparison
Dadha Pharma Distribution Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Livanova India Private Limited | ₹192.91 Cr (FY 2025) | 41.0% | Gurgaon, Haryana, India | |||
| Anm Pharma Private Limited | ₹190.81 Cr (FY 2025) | 3.0% | New Delhi, Delhi, India | |||
| Kaushal Pharmaceuticals Private Limited | ₹186.1 Cr (FY 2025) | 13.0% | Kolkata, West Bengal, India | |||
| Dadha Pharma Distribution Limitedthis company | ₹182.54 Cr (FY 2025) | -₹19.9 Lakh | -0.1% | -7.0% | 33 | Mumbai, Maharashtra, India |
| Molkem Chemicals Private Limited | ₹178.68 Cr (FY 2025) | 63.0% | Ahmedabad, Gujarat, India | |||
| Medihauxe Pharma Private Limited | ₹175.69 Cr (FY 2023) | -4.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Dadha Pharma Distribution Limited, buy the company report.
Auditor
Dadha Pharma Distribution Limited is audited by Deloitte Haskins & Sells LLP for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Deloitte Haskins & Sells LLP | FY 2023 | 117366W/W-100018 |
Shareholding
The shareholding of Dadha Pharma Distribution Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Dadha Pharma Distribution Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 22 Feb 2016 | 10622565 | Idbi Bank Limited | ₹20 Cr | Satisfied |
To see the full charge records of Dadha Pharma Distribution Limited, buy the company report.
Total charge records: 1 View all charges
Deals & funding
Dadha Pharma Distribution Limited has 5 deals on record (5 acquisitions); the latest was in March 2021.
Deals on record (5 of 5)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2021 | Acquisition | ₹8.12 Cr | Buyer: Reliance Retail Ventures Limited Seller: Tresara Health Limited |
| Aug 2020 | Acquisition | ₹8.18 Cr | Buyer: Reliance Retail Ventures Limited |
| Dec 2015 | Acquisition | ₹4.91 Cr | Buyer: Tresara Health Limited |
| Oct 2015 | Acquisition | ₹9 Lakh | Buyer: Tresara Health Limited |
| Oct 2015 | Acquisition | Undisclosed | Buyer: Tresara Health Limited Seller: 2 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Dadha Pharma Distribution Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
Credit ratings & regulatory alerts
Dadha Pharma Distribution Limited was last rated by Crisil on 31 Oct 2020.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 31 Oct 2020 |
To see the full credit ratings and regulatory alerts of Dadha Pharma Distribution Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Dadha Pharma Distribution Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Dadha Pharma Distribution Limited has a workforce of 33 employees on its EPFO records as of May 2026, across 2 active EPFO establishments.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 33 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Dadha Pharma Distribution Limited, buy the company report.
GST
Dadha Pharma Distribution has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 32AAFCD4589H2ZI | Kerala | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Dadha Pharma Distribution Limited, buy the company report.
Recent activity
Dadha Pharma Distribution Limited has 6 board changes on record since 2015: 3 appointments and 3 cessations. The latest: Advait Suhas Pandit ceased to be Additional Director on 15 Sep 2021.
Frequently asked questions
Dadha Pharma Distribution is an active public limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 15 September 2015 (11+ years old) and is registered under CIN U74900MH2015PLC447671.
Dadha Pharma Distribution has 3 current directors:
- Jethusingh Sohan Singh Bhati - Whole-Time Director
- Mohanchand Pradeep Dadha - Director
- Advait Suhas Pandit - Director
The latest financial statements of Dadha Pharma Distribution on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 08 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Dadha Pharma Distribution is 32AAFCD4589H2ZI, registered in Kerala. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Dadha Pharma Distribution is U74900MH2015PLC447671. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Dadha Pharma Distribution was incorporated on 15 September 2015, making it 11+ years old. It is registered with the Registrar of Companies, Mumbai.
Dadha Pharma Distribution has 5 deals on record (5 acquisitions); the latest was in March 2021.
The peers of Dadha Pharma Distribution by revenue are Livanova India Private Limited, Anm Pharma Private Limited, Kaushal Pharmaceuticals Private Limited, Molkem Chemicals Private Limited, Medihauxe Pharma Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Advait Suhas Pandit ceased to be Additional Director on 15 Sep 2021. Advait Suhas Pandit was appointed as Director on 21 Jan 2021. Subhagmal Mohanchand Dadha ceased to be Director on 21 Jan 2021. Dadha Pharma Distribution has 6 board changes on record in total.
Dadha Pharma Distribution can be reached through the website ril.com. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Dadha Pharma Distribution is at Floor – 4 Plot – 298302 Court House, Lokmanya Tilak Marg, Mumbai, Maharashtra, India – 400002.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
